A multi-biomarker model identifies patients with PAH-CHD at highest risk for mortality

被引：0
|
作者：
Van Dissel, A. C. [1 ]
Blok, I. M. [1 ]
Zwinderman, A. H. [2 ]
Van Dijk, A. P. J. [3 ]
Duijnhouwer, A. L. [3 ]
Mulder, B. J. M. [1 ]
Bouma, B. J. [1 ]
机构：
[1] Acad Med Ctr Amsterdam, Cardiol, Amsterdam, Netherlands
[2] Acad Med Ctr Amsterdam, Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Cardiol, Nijmegen, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2103
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [1] IMPORTANCE OF CLASSIFICATION AND REASSESSMENT IN PATIENTS WITH PAH-CHD: THE NORPAP DATABASE
    Abraham, Dilip
    Bingham, Ruth
    Ranu, Ranu
    Head, Catherine
    Lewis, Clive
    Freeman, Leisa J.
    HEART, 2017, 103 : A54 - A55
  • [2] IMPORTANCE OF CLASSIFICATION AND REASSESSMENT IN PATIENTS WITH PAH-CHD: THE NORPAP DATABASE
    Bingham, R.
    Abraham, D.
    Baral, R.
    Edge, H.
    Head, C.
    Lewis, C.
    Freeman, L. J.
    HEART, 2018, 104 : A1 - A1
  • [3] Mortality rates according to deterioration of various follow-up parameters in PAH-CHD
    Schuijt, M. T. U.
    Blok, I. M.
    Van Riel, A. C. M. J.
    Zwinderman, A. H.
    Van Dijk, A. P. J.
    Mulder, B. J. M.
    Bouma, B. J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 26 - 27
  • [4] A MULTI-BIOMARKER APPROACH FOR THE PREDICTION OF CARDIOVASCULAR MORTALITY IN HEMODYALISIS PATIENTS
    Selim, G.
    Stojceva-Taneva, O.
    Gelev, S.
    Stojcev, N.
    Dzekova, P.
    Trajcevska, L.
    Asani, A.
    Busletic, I.
    Pavleska, S.
    Sikole, A.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 489 - 489
  • [5] Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD
    Zhu, Tengteng
    Wu, Panyun
    Tan, Zhen
    Jin, Quan
    Chen, Yusi
    Li, Lian
    Chen, Zewei
    Tang, Yirui
    Li, Jiang
    Fang, Zhenfei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Multi-biomarker mortality prediction in patients with aortic stenosis undergoing valve replacement
    Spampinato, Ricardo A.
    Bochen, Rafal
    Sieg, Franz
    Weiss, Stefan
    Kornej, Jelena
    Haunschild, Josephina
    von Aspern, Konstantin
    Strotdrees, Elfriede
    Noack, Thilo
    Lehmann, Sven
    Etz, Christian
    Borger, Michael A.
    JOURNAL OF CARDIOLOGY, 2020, 76 (02) : 154 - 162
  • [7] A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure
    Richter, Bernhard
    Koller, Lorenz
    Hohensinner, Philipp J.
    Zorn, Gerlinde
    Brekalo, Mira
    Berger, Rudolf
    Moertl, Deddo
    Maurer, Gerald
    Pacher, Richard
    Huber, Kurt
    Wojta, Johann
    Huelsmann, Martin
    Niessner, Alexander
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1251 - 1257
  • [8] Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis
    Chen, Fa-chao
    Xu, Yin-chuan
    Zhang, Zhao-cai
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (07): : 537 - 548
  • [9] Multi-biomarker analysis in patients after TAVI
    Mirna, M.
    Wernly, B.
    Paar, V.
    Pistulli, R.
    Rohm, I.
    Jung, C.
    Figulla, H. -R.
    Yilmaz, A.
    Schulze, P. C.
    Hoppe, U.
    Kretzschmar, D.
    Lichtenauer, M.
    Lauten, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S98 - S98
  • [10] Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)
    Luo, Jun
    Li, Yuanchang
    Chen, Jingyuan
    Qiu, Haihua
    Chen, Wenjie
    Luo, Xiaoqin
    Chen, Yusi
    Tan, Yingjie
    Li, Jiang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345